Evan B. Bryson, PharmD, BCOP | Authors

Expert Commentary on the Product Profile of Amivantamab-vmjw

March 12, 2022

In an interview with ONCOLOGY®, Evan B. Bryson, PharmD, BCOP, offers a comprehensive review of real-world treatment considerations of amivantamab as therapy for patients with non–small cell lung cancer.